Morphic Holding Inc (STU:31Y)
€ 51 0 (0%) Market Cap: 2.60 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 4.62 GF Score: 42/100

Morphic Holding Inc at Canaccord Genuity Growth Conference Transcript

Aug 10, 2023 / 03:30PM GMT
Release Date Price: €48.4 (-6.92%)
Edward Nash
Canaccord Genuity Group Inc. - Analyst

One for joining us, my name is Edward Nash. I am a senior analyst on the biotech team here at Canaccord Genuity. And I'm joined by my colleague, [Shin Leon], who works in the team with me. We have the pleasure of having with us today the management team of Morphic Therapeutic. With us is the CEO, Praveen Tipirneni; and the Senior Vice President of IR and Corporate Communications, Chris Erdman. Appreciate you both joining us today.

Praveen Tipirneni
Morphic Holding, Inc. - CEO

Thanks you for inviting us, and you guys are quite bold having this in August. Get quite a turnout for it.

Edward Nash
Canaccord Genuity Group Inc. - Analyst

I know, right. A lot of headwinds.

Praveen Tipirneni
Morphic Holding, Inc. - CEO

Yeah.

Edward Nash
Canaccord Genuity Group Inc. - Analyst

So I want to start the conversation. Just to get your audience a little bit of background on the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot